Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jiirgen B. Bulitta"'
Autor:
Jiirgen B. Bulitta, Fritz Sörgel, George L. Drusano, Cornelia B. Landersdorfer, Ulrike Holzgrabe, Johannes Gusinde, Friedrich F. Hennig, Martina Kinzig
Publikováno v:
Antimicrobial Agents and Chemotherapy. 53:2074-2081
Moxifloxacin is a fluoroquinolone with a broad spectrum of activity and good penetration into many tissues, including bone. Penetration of moxifloxacin into bone has not yet been studied using compartmental modeling techniques. Therefore, we determin
Autor:
William J. Jusko, Alan Forrest, Jiirgen B. Bulitta, Brian T. Tsuji, Jenny C Yang, Neang S. Ly
Publikováno v:
Antimicrobial Agents and Chemotherapy. 53:46-56
Pseudomonas aeruginosa is an opportunistic, gram-negative pathogen responsible for high morbidity and mortality (19). P. aeruginosa has multiple mechanisms of resistance to antibiotics, including efflux pumps, the enzymatic degradation of antibiotics
Autor:
Jiirgen B. Bulitta, Ping Zhao, James Pratt, Hans Gelderblom, Richard Daifuku, Robert D. Arnold, Axel-R. Hanauske, Ahmad Awada, Dean R. Kessler, William J. Jusko, Gabriel Luciano
Publikováno v:
Cancer Chemotherapy and Pharmacology. 63:1035-1048
Our objective was to build a mechanism-based pharmacodynamic model for the time course of neutropenia in cancer patients following paclitaxel treatment with a tocopherol-based Cremophor-free formulation (Tocosol Paclitaxel) and Cremophor EL-formulate
Publikováno v:
Pharmazie in unserer Zeit. 30:418-427